2023
DOI: 10.3390/toxics11121012
|View full text |Cite
|
Sign up to set email alerts
|

Xylazine Poisoning in Clinical and Forensic Practice: Analysis Method, Characteristics, Mechanism and Future Challenges

Tingting Mai,
Youyou Zhang,
Shuquan Zhao

Abstract: Xylazine abuse is emerging globally, while the identification of xylazine lethal cases poses a great challenge in clinical and forensic practice. The non-specific symptoms delay the diagnosis and treatment of xylazine poisoning, the pathological changes and lethal concentration of xylazine in body fluid and organs of fatal xylazine poisoning cases are seldom reported and the other toxins detected in such cases complicate the role of xylazine in the cause of death. Therefore, we carefully reviewed related updat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…Moreover, antibodies demonstrate higher safety profiles and selectivity against the targeted drug making them a viable emergency measure for opioid overdose, even in cases where the presence of xylazine is uncertain. 19 We also highlight that the mechanism of action underlying antibody therapy allows for its potential application across different drugs, thereby streamlining the development of therapeutics against emerging substances and those with multifaceted receptors like xylazine.…”
mentioning
confidence: 99%
“…Moreover, antibodies demonstrate higher safety profiles and selectivity against the targeted drug making them a viable emergency measure for opioid overdose, even in cases where the presence of xylazine is uncertain. 19 We also highlight that the mechanism of action underlying antibody therapy allows for its potential application across different drugs, thereby streamlining the development of therapeutics against emerging substances and those with multifaceted receptors like xylazine.…”
mentioning
confidence: 99%